SCORE

75

TBPH: THERAVANCE BIOPHARMAA I is a Buy


The current rating for TBPH is 75, which is 50% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.